US FDA approves Ionis-AstraZeneca drug for nerve disease

The US Food and Drug Administration (FDA) has approved a drug from Ionis Pharmaceuticals and its partner AstraZeneca to treat nerve damage caused by a rare, life-shortening disease. The drug is approved for patients with polyneuropathy, or nerve damage caused by hereditary transthyretin amyloidosis.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM